A new genetic test built on DNA's cousin
Plenty of companies have seen success in DNA testing. Now a California-based company is betting that it can do the same with RNA testing as well.
That company, Ambry Genetics, announced this week that it is launching a test to turn up more at-risk patients by looking at ribonucleic acid, which carries out orders for making proteins. The test will screen RNA transcripts for 18 genes, alongside with the usual DNA analysis.
The key questions, as STAT’s Rebecca Robbins points out, are whether the test can get traction and whether insurers will consider paying more for it. In other words, how useful will the test be for patients?
Read more.
That company, Ambry Genetics, announced this week that it is launching a test to turn up more at-risk patients by looking at ribonucleic acid, which carries out orders for making proteins. The test will screen RNA transcripts for 18 genes, alongside with the usual DNA analysis.
The key questions, as STAT’s Rebecca Robbins points out, are whether the test can get traction and whether insurers will consider paying more for it. In other words, how useful will the test be for patients?
Read more.
.png)
No hay comentarios:
Publicar un comentario